Harrow Health Company Leadership

HROWL Stock  USD 25.39  0.04  0.16%   
Inspection of Harrow Health's management performance can provide insight into the company performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

Harrow Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Harrow Health's future performance. Based on our forecasts, it is anticipated that Harrow will maintain a workforce of about 3 employees by December 2024.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Symbol  HROWL
Name  Harrow Health 8625
TypeStock
Country  
 United States
Exchange  NASDAQ

Information on Harrow Health 8625 Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Harrow Health Management Team Effectiveness

Return On Capital Employed is expected to rise to 0 this year, although the value of Return On Tangible Assets will most likely fall to (0.17). At this time, Harrow Health's Intangibles To Total Assets are quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 13.26 this year, although the value of Net Tangible Assets will most likely fall to about 1.2 M. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities.
Common Stock Shares Outstanding is expected to rise to about 34.2 M this year, although the value of Net Loss is projected to rise to (12 M).

Harrow Health Workforce Comparison

Harrow Health 8625 is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,129. Harrow Health adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Harrow Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Harrow Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2023-12-01
1.5
3
2
 52,500 
 29,778 
2023-09-01
1.1667
7
6
 1,431,800 
 1,931,398 
2023-06-01
4.0
8
2
 1,596,976 
 297,633 
2023-03-01
0.5
3
6
 201,000 
 280,223 
2022-03-01
0.8333
5
6
 231,343 
 342,934 
2021-09-01
5.0
15
3
 1,531,001 
 23,900 
2021-06-01
1.6667
10
6
 1,090,660 
 2,889,461 
2021-03-01
1.6667
5
3
 455,000 
 237,500 
2020-09-01
1.6667
10
6
 355,298 
 93,798 
2020-06-01
15.0
15
1
 778,924 
 600,000 
2020-03-01
0.75
6
8
 467,718 
 457,719 
2019-12-01
0.5
2
4
 195,000 
 208,000 
2019-06-01
1.3333
4
3
 38,860 
 30,000 
2019-03-01
1.6667
5
3
 350,000 
 30,000 
2018-03-01
2.5
5
2
 310,000 
 60,000 
2017-06-01
2.3333
7
3
 317,892 
 255,000 
2017-03-01
4.0
4
1
 322,000 
 20,000 
2016-12-01
4.0
8
2
 885,000 
 283,709 
2016-06-01
5.0
10
2
 1,570,950 
 1,207,500 
2016-03-01
4.0
4
1
 150,000 
 15,000 
2015-06-01
2.3333
7
3
 78,207 
 425,282 
2015-03-01
2.0
4
2
 307,500 
 25,000 
2014-09-01
2.0
6
3
 98,367 
 90,465 
2012-12-01
0.5
1
2
 38,014 
 0.00 
2012-09-01
1.0
7
7
 6,371,623 
 15,979,883 
2012-06-01
2.0
14
7
 23,285,286 
 778,812 
2012-03-01
0.6667
8
12
 3,133,261 
 13,266,761 
2011-12-01
0.25
1
4
 493.00 
 4,928 
2009-12-01
1.0
1
1
 215,000 
 85,000 
2008-12-01
5.0
5
1
 290,000 
 10,000 
2008-09-01
7.0
7
1
 7,900 
 10,000 
2008-06-01
3.0
3
1
 304,200 
 300,000 

About Harrow Health Management Performance

The success or failure of an entity such as Harrow Health 8625 often depends on how effective the management is. Harrow Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Harrow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Harrow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.16)(0.17)
Return On Assets(0.08)(0.08)
Return On Equity(0.34)(0.36)
When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity
0.4484
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.